|

Envafolimab Clinical Trials

6 actively recruiting trials

▼ -1 trial since June 2026

Pipeline

Phase 1: 1Phase 2: 3Phase 3: 1Phase 1/2: 1

Top Sponsors

3D Medicines (Sichuan) Co., Ltd.2
Tianjin Medical University Second Hospital1
Sir Run Run Shaw Hospital1
Kangabio AUSTRALIA LTD PTY1
First Affiliated Hospital of Fujian Medical University1

Indications

Cancer6
CDK12 Gene Mutation1
Advanced Endometrial Cancer1
Advanced or Metastatic Solid Tumors1
Rectal Cancer1

Other6 trials

A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients

Phase 1

Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer

Phase 2

ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors

Phase 2

Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma

Phase 3

RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure

Phase 1/2

Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.